文献速递临床试验与 GCP

肥胖患者手术室插管时是否使用面罩通气的随机多中心试验研究方案(VENT OR NOT)

Intubation of obese patients in the operating room with or without bag-mask ventilation: study protocol for a randomized multicenter trial (VENT OR NOT).
PubMed 文献 · Trials · 2025-11-11

VENT OR NOT 研究是一项前瞻性、多中心、开放标签、随机试验,纳入体重指数≥35 kg/m²的择期手术需气管插管的肥胖患者702例,比较标准顺序插管(VENT策略,诱导与插管之间使用面罩通气)与快速顺序插管(NO VENT策略,不使用面罩通气)对插管相关并发症的预防效果,主要结局为从全麻诱导至插管后10分钟内复合并发症指标,包括氧饱和度下降<95%、首次插管失败、误吸或反流、以及收缩压<80 mmHg定义的严重低血压,该试验已于2023年9月在13家法国学术与非学术医院启动入组,预计2025年9月完成。

要点

  • VENT OR NOT 研究比较肥胖患者插管时面罩通气与不面罩通气两种策略的插管相关并发症。
  • 纳入标准为体重指数≥35 kg/m²的择期手术需气管插管患者,计划样本量702例。
  • 主要结局为诱导至插管后10分钟内的复合并发症指标,包括氧饱和度下降、首次插管失败、误吸或反流及严重低血压。

核心结论

  • 该研究旨在比较标准顺序插管(VENT策略)与快速顺序插管(NO VENT策略)在严重肥胖择期手术患者中预防插管相关并发症的优效性,目前为研究方案,尚未报告结果。

研究设计与样本

  • 前瞻性、多中心、开放标签、随机对照试验,纳入体重指数≥35 kg/m²的择期手术需气管插管的肥胖患者702例。
  • 计划在13家法国学术与非学术医院开展,入组于2023年9月开始,预计2025年9月完成。
  • 研究经伦理委员会批准,按照赫尔辛基宣言和药物临床试验质量管理规范原则实施。

主要发现

  • 主要结局为从全麻诱导至插管后10分钟内的复合并发症指标,包括氧饱和度下降<95%、首次插管失败、误吸或反流、以及收缩压<80 mmHg定义的严重低血压。
  • 研究设计为评估VENT策略相对于NO VENT策略在预防插管相关并发症方面的优效性,尚未报告结果数据。

关键数值与推荐

  • 纳入标准为体重指数≥35 kg/m²且择期手术需气管插管的肥胖患者。
  • 主要复合结局包括氧饱和度下降<95%、首次插管失败、误吸或反流、收缩压<80 mmHg的严重低血压,观察时间窗为全麻诱导至插管后10分钟。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Almost two-thirds of the adults in Europe are overweight or obese. Obese patients are at higher risk of complications, especially during intubation. Therefore, the management of general anesthesia is crucial. Regarding intubation, there is no consensus among anesthesiologists between the two strategies: standard sequence intubation (i.e., with bag-mask ventilation between induction and intubation) vs. rapid sequence intubation (i.e., without bag-mask ventilation between induction and intubation) assuming that these patients are at high risk of inhalation and desaturation during apnea. This study aims to compare the incidence of intubation-related complications between these two strategies in severely obese patients undergoing elective surgery. METHODS: The VENT OR NOT study is a prospective, multicenter, open-label, randomized trial including obese patients with a body mass index ≥ 35 kg/m2 requiring tracheal intubation before scheduled surgery. We will assess the superiority of the standard sequence intubation ("VENT strategy") compared with the rapid sequence intubation ("NO VENT strategy") to prevent intubation-related complications in 702 obese patients. Enrolment started in September 2023 in 13 French academic and nonacademic hospitals and is expected to finish in September 2025. The primary outcome is a composite criterion of complications occurring from the induction of general anesthesia up to 10 min after intubation including: oxygen desaturation < 95%, intubation failure on the first attempt, aspiration or regurgitation, and severe hypotension defined as a systolic blood pressure < 80 mmHg. The VENT OR NOT trial began after ethics committee approval has been obtained and is carried out according to the principles of the Declaration of Helsinki and the Good Clinical Practice guidelines. DISCUSSION: The VENT OR NOT trial is the first randomized controlled trial designed to investigate whether the "VENT strategy" reduces the risk of intubation-related complications compared with the "NO VENT strategy" for elective surgery. TRIAL REGISTRATION: ClinicalTrials.gov NCT05930678. Registered on June 1, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Znaïdi S, Deransy R, Asehnoune K, et al. Intubation of obese patients in the operating room with or without bag-mask ventilation: study protocol for a randomized multicenter trial (VENT OR NOT). Trials. 2025. PMID: 41219812. doi:10.1186/s13063-025-09114-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。